The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Apr. 22, 2019
Applicant:

China Medical University Hospital, Taichung, TW;

Inventors:

Der-Yang Cho, Taichung, TW;

Shao-Chih Chiu, Taichung, TW;

Chia-Ing Jan, Taichung, TW;

Chih-Ming Pan, Taichung, TW;

Shi-Wei Huang, Taichung, TW;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01); A61K 31/282 (2006.01); A61K 31/4188 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01); C12N 5/0783 (2010.01); C12N 9/22 (2006.01); C07K 14/74 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 31/282 (2013.01); A61K 31/4188 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C07K 14/70539 (2013.01); C07K 16/2833 (2013.01); C12N 5/0646 (2013.01); C12N 9/22 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/565 (2013.01); C07K 2319/00 (2013.01); C12N 2510/00 (2013.01); C12N 2800/80 (2013.01);
Abstract

The present disclosure relates to a chimeric antigen receptor, a nucleic acid, a chimeric antigen receptor expression plasmid, a chimeric antigen receptor expressing cell, a pharmaceutical composition for treating cancer, and use of the chimeric antigen receptor expressing cell. The chimeric antigen receptor is specific to human leukocyte antigen G. The nucleic acid encodes the chimeric antigen receptor. The chimeric antigen receptor expression plasmid expresses the chimeric antigen receptor. The chimeric antigen receptor expressing cell is obtained by transducing the chimeric antigen receptor into an immune cell. The pharmaceutical composition for treating cancer includes the chimeric antigen receptor expressing cell and a pharmaceutically acceptable carrier.


Find Patent Forward Citations

Loading…